Related Experiment Video
Updated: Oct 13, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Accelerating pre-formulation investigations in early drug product life cycles using predictive methodologies and
Harsh S Shah1, Kaushalendra Chaturvedi1, Shanming Kuang1
1J-Star Research Inc., 6 Cedarbrook Drive, Cranbury, NJ 08512, USA.
Abstract:
Precisely developed computational methodologies can allow the drug product lifecycle process to be time-efficient, cost-effective and reliable through a thorough fundamental understanding at the molecular level. Computational methodologies include computational simulations, virtual screening, mathematical modeling and predictive tools. In light of current trends and increased expectations of product discovery in early pharmaceutical development, we have discussed different case studies. These case studies clearly demonstrate the successful application of predictive tools alone or in combination with analytical techniques to predict the physicochemical properties of drug substances and drug products, thereby shortening research and development timelines. The overall goal of this report is to summarize unique predictive methodologies, which can assist pharmaceutical scientists in achieving time-sensitive research goals and avoiding associated risks that can potentially affect the drug product quality.
More Related Videos
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
07:45Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
Published on: October 25, 2024
Related Concept Videos
Preclinical Development: Overview
Drug Discovery: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Product Performance: In Vitro–In Vivo Correlation
Clinical Trials: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment